デフォルト表紙
市場調査レポート
商品コード
1009359

スピルリナ市場の成長機会・成長予測 (2020-2027年):タイプ・用途・形態・地域別

Spirulina Market by Type, Application, and Formulation : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 246 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.86円
スピルリナ市場の成長機会・成長予測 (2020-2027年):タイプ・用途・形態・地域別
出版日: 2021年04月01日
発行: Allied Market Research
ページ情報: 英文 246 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のスピルリナの市場規模は予測期間中10.5%のCAGRで推移し、2019年の3億9360万米ドルから、2027年には8億9761万米ドルの規模に成長すると予測されています。

スピルリナは栄養成分が高く、栄養補助食品としての利用の増加が市場成長を促進する主な要因です。また、癌、心血管疾患、免疫疾患などの有病率の上昇により、消費者によるスピルリナ需要が高まっています。さらに、医療費の増加や可処分所得の増加などの要因も同市場の成長を促進すると予測されています。一方で、資源の限定性が市場のさらなる成長を抑制する見通しです。

当レポートでは、世界のスピルリナの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、特許動向、ケーススタディ、市場規模の推移・予測、タイプ・用途・形態・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 親市場の概要
  • ポーターの分析
  • 価格分析
  • 市場の進化・産業のロードマップ
  • 特許分析
  • 市場シェア分析
  • バリューチェーン分析
  • 法規制の影響
  • 産業課題の分析
  • ケーススタディ
  • 市場動向
  • 誤った認識
  • 企業対応
  • 生産部門のマーケティング戦略
  • 欧州における消費動向
  • 動物飼料への使用
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • COVID-19:影響分析

第4章 市場分析・予測:タイプ別

  • アルスロスピラプラテンシス
  • アルスロスピラマキシマ
    • 主要動向・成長機会
    • 市場規模・予測:消費サイド
    • 市場規模・予測:生産サイド
    • 市場分析:国別

第5章 市場分析・予測:用途別

  • ニュートラシューティカルズ
  • 化粧品
  • 食品・飲料
  • 動物飼料
  • その他
    • 主要動向・成長機会
    • 市場規模・予測:消費サイド
    • 市場規模・予測:生産サイド
    • 市場分析:国別

第6章 市場分析・予測:形態別

  • パウダー
  • タブレット&カプセル
  • 液体
  • 顆粒・ゲル化剤
    • 主要動向・成長機会
    • 市場規模・予測:消費サイド
    • 市場規模・予測:生産サイド
    • 市場分析:国別

第7章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • 主要動向・成長機会
    • 市場規模・予測:用途別
    • 市場規模・予測:形態別
    • 市場規模・予測:国別

第8章 企業プロファイル

  • ALGENOL BIOFUELS INC.
  • CABASSI & GIURIATI SPA
  • CYANOTECH CORPORATION
  • DDW INC.
  • DIC CORPORATION
  • DOHLER GmbH
  • DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.
  • ECHLORIAL
  • E.I.D. PARRY LIMITED
  • GIVAUDAN INTERNATIONAL SA
  • PROLGAE SPIRULINA SUPPLIES PVT. LTD.
  • POND TECHNOLOGIES INC.
  • SENSIENT TECHNOLOGIES CORPORATION
図表

LIST OF TABLES

  • TABLE 01.CASE STUDY D
  • TABLE 02.GLOBAL SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027($MILLION)
  • TABLE 03.GLOBAL SPIRULINA MARKET, BY TYPE, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • TABLE 04.SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY REGION, BY CONSUMPTION SIDE, 2019-2027($MILLION)
  • TABLE 05.SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY REGION, BY CONSUMPTION SIDE, 2019-2027($MILLION)
  • TABLE 06.GLOBAL SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 07.GLOBAL SPIRULINA MARKET, BY APPLICATION, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 08.SPIRULINA MARKET FOR NUTRACEUTICALS, BY CONSUMPTION SIDE, BY REGION, 2019-2027, ($MILLION)
  • TABLE 09.SPIRULINA MARKET FOR COSMETICS, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 10.SPIRULINA MARKET FOR FOOD & BEVERAGES, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 11.SPIRULINA MARKET FOR ANIMAL FEED, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 12.SPIRULINA MARKET FOR OTHER APPLICATIONS, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 13.GLOBAL SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 14.GLOBAL SPIRULINA MARKET, BY FORMULATION, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 15.SPIRULINA MARKET FOR POWDER, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 16.SPIRULINA MARKET FOR TABLET & CAPSULE, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 17.SPIRULINA MARKET FOR LIQUID, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 18.SPIRULINA MARKET FOR GRANULE & GELLING AGENT, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 19.SPIRULINA MARKET, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 20.SPIRULINA MARKET, BY REGION, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 21.SPIRULINA MARKET, BY REGION, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 22.NORTH AMERICA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 23.NORTH AMERICA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 24.NORTH AMERICA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 25.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 26.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 27.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 28.U.S. SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 29.U.S. SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 30.U.S. SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 31.CANADA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 32.CANADA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 33.CANADA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 34.MEXICO SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 35.MEXICO SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 36.MEXICO SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 37.EUROPE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 38.EUROPE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 39.EUROPE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 40.EUROPE SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 41.EUROPE SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 42.EUROPE SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 43.GERMANY SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 44.GERMANY SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 45.GERMANY SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 46.FRANCE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 47.FRANCE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 48.FRANCE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 49.UK SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 50.UK SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 51.UK SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 52.ITALY SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 53.ITALY SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 54.ITALY SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 55.SPAIN SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 56.SPAIN SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 57.SPAIN SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 58.REST OF EUROPE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 59.REST OF EUROPE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 60.REST OF EUROPE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 61.ASIA-PACIFIC SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 62.ASIA-PACIFIC SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 63.ASIA-PACIFIC SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 64.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 65.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 66.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 67.JAPAN SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 68.JAPAN SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 69.JAPAN SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 70.CHINA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 71.CHINA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 72.CHINA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 73.INDIA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 74.INDIA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 75.INDIA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 76.AUSTRALIA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 77.AUSTRALIA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 78.AUSTRALIA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 79.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 80.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 81.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 82.LAMEA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 83.LAMEA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 84.LAMEA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 85.LAMEA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 86.LAMEA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 87.LAMEA SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 88.BRAZIL SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 89.BRAZIL SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 90.BRAZIL SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 91.SOUTH AFRICA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 92.SOUTH AFRICA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 93.SOUTH AFRICA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 94.REST OF LAMEA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 95.REST OF LAMEA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 96.REST OF LAMEA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 97.ALGENOL: COMPANY SNAPSHOT
  • TABLE 98.ALGENOL: OPERATING SEGMENTS
  • TABLE 99.ALGENOL: PRODUCT PORTFOLIO
  • TABLE 100.CABASSI & GIURIATI: COMPANY SNAPSHOT
  • TABLE 101.CABASSI & GIURIATI: OPERATING SEGMENTS
  • TABLE 102.CYANOTECH: COMPANY SNAPSHOT
  • TABLE 103.CYANOTECH: OPERATING SEGMENTS
  • TABLE 104.CYANOTECH: PRODUCT PORTFOLIO
  • TABLE 105.DDW INC: COMPANY SNAPSHOT
  • TABLE 106.DDW INC: OPERATING SEGMENTS:
  • TABLE 107.DDW INC: PRODUCT PORTFOLIO
  • TABLE 108.DIC: COMPANY SNAPSHOT
  • TABLE 109.DIC: OPERATING SEGMENTS
  • TABLE 110.DIC: PRODUCT PORTFOLIO
  • TABLE 111.DOHLER: COMPANY SNAPSHOT
  • TABLE 112.DOHLER: OPERATING SEGMENTS
  • TABLE 113.DOHLER: PRODUCT PORTFOLIO
  • TABLE 114.DONGTAI: COMPANY SNAPSHOT
  • TABLE 115.DONGTAI: OPERATING SEGMENTS
  • TABLE 116.DONGTAI: PRODUCT PORTFOLIO
  • TABLE 117.ECHLORIAL: COMPANY SNAPSHOT
  • TABLE 118.ECHLORIAL: OPERATING SEGMENTS
  • TABLE 119.ECHLORIAL PRODUCT PORTFOLIO
  • TABLE 120.PARRY: COMPANY SNAPSHOT
  • TABLE 121.PARRY: OPERATING SEGMENTS
  • TABLE 122.PARRY: PRODUCT PORTFOLIO
  • TABLE 123.GIVAUDAN: COMPANY SNAPSHOT
  • TABLE 124.GIVAUDAN: OPERATING SEGMENTS
  • TABLE 125.GIVAUDAN: PRODUCT PORTFOLIO
  • TABLE 126.PROLGAE: COMPANY SNAPSHOT
  • TABLE 127.PROLGAE: OPERATING SEGMENTS
  • TABLE 128.PROLGAE SPIRULINA SUPPLIES PVT. LTD: PRODUCT PORTFOLIO
  • TABLE 129.POND TECHNOLOGIES INC: COMPANY SNAPSHOT
  • TABLE 130.POND TECHNOLOGIES INC: OPERATING SEGMENTS
  • TABLE 131.POND TECHNOLOGIES INC: PRODUCT PORTFOLIO
  • TABLE 132.SENSIENT: COMPANY SNAPSHOT
  • TABLE 133.SENSIENT: OPERATING SEGMENTS
  • TABLE 134.SENSIENT: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.TOP INVESTMENT POCKETS, 2019
  • FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 03.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 04.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 05.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 06.HIGH INTENSITY OF RIVALRY
  • FIGURE 07.PRICING ANALYSIS, BY REGION, 2019 & 2027
  • FIGURE 08.PATENT ANALYSIS, BY REGION
  • FIGURE 09.PATENT ANALYSIS, BY APPLICANT
  • FIGURE 10.PATENT ANALYSIS, BY YEAR
  • FIGURE 11.MARKET SHARE ANALYSIS, 2019
  • FIGURE 12.VALUE CHAIN ANALYSIS
  • FIGURE 13.INDUSTRY PAIN POINT ANALYSIS
  • FIGURE 14.GLOBAL SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 16.GLOBAL SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.GLOBAL SPIRULINA MARKET FOR NUTRACEUTICALS, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR NUTRACEUTICALS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.GLOBAL SPIRULINA MARKET FOR COSMETICS, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR COSMETICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 22.GLOBAL SPIRULINA MARKET FOR FOOD & BEVERAGES, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR FOOD & BEVERAGES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 24.GLOBAL SPIRULINA MARKET FOR ANIMAL FEED, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR ANIMAL FEED, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 26.GLOBAL SPIRULINA MARKET FOR OTHER SPIRULINA, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 28.GLOBAL SPIRULINA MARKET FOR POWDER, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR POWDER, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 30.GLOBAL SPIRULINA MARKET FOR TABLET & CAPSULE, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 31.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR TABLET & CAPSULE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 32.GLOBAL SPIRULINA MARKET FOR LIQUID, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 33.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR LIQUID, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 34.GLOBAL SPIRULINA MARKET FOR GRANULE & GELLING, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 35.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR GRANULE & GELLING AGENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 36.CYANOTECH: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 37.CYANOTECH: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 38.CYANOTECH: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 39.DIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 40.DIC: REVENUE SHARE BY PRODUCT, 2019 (%)
  • FIGURE 41.DIC: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 42.PARRY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 43.PARRY: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 44.PARRY: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 45.GIVAUDAN: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 46.GIVAUDAN: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 47.GIVAUDAN: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 48.SENSIENT: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 49.SENSIENT: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 50.SENSIENT: REVENUE SHARE BY REGION, 2020 (%)
目次
Product Code: LI_184222 / A03875

The global spirulina market was valued at $393.6 million in 2019, and is projected to reach $897.61 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.

Spirulina is a natural algae powder known as cyanobacteria that includes potent level of proteins, antioxidants, and vitamin B and other nutrients. It exhibits various benefits such as lowering of LDL and triglyceride levels. It also exhibits anticancer properties, helps reduce blood pressure, is effective against anemia, and improves muscle strength.

Spirulina is used in various applications, such as food & beverages, dietary supplements, pharmaceuticals, animal & aquaculture, and cosmetic & personal care industry. In the last two years, multiple products were launched in the food & beverage industry in which it was used as a primary ingredient. Natural blue and green color produced from it is in high demand, and witnessed a strong market growth in the last two years.

The increase in use of spirulina as a dietary food supplement, owing to its high nutritional content is the major factor that drives the growth of the spirulina market. Furthermore, increase in adoption of healthy food in developed countries fuel the market growth in the food & beverages sector. The rise in prevalence of cancer, cardiovascular diseases, immune diseases, and other diseases boosts the demand for spirulina among its end users.

Furthermore, increase in healthcare expenditure and rise in disposable income among the population is anticipated to foster the market growth. However, limited resource of spirulina as it is extracted from freshwater sources that are available in very few areas hinders the market growth. Emerging economies such as India, China, Mexico, and Brazil are anticipated to provide new opportunities for the market growth during the forecast period.

The spirulina market is segmented into type, application, drug formulation, and region. By type, the market is bifurcated into Arthrospira Platensis and Arthrospira Platensis. By application, it is categorized into nutraceuticals, cosmetics, food & beverages, agriculture, feed, and others. By drug formulation, it is categorized into powder, tablet & capsule, liquid, and granule & gelling agent. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides a comprehensive analysis of the key players operating in the global spirulina market. These players include Cyanotech Corporation, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd., Algenol Biofuels Inc., Prolgae, Sensient Technologies Corporation, Parry Neutraceuticals, DDW Inc., Naturex S.A., and Algatec.

The other players operating in the global spirulina market include GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., Fraken Biochem Co., Ltd., and Far East Bio-Tec Co. Ltd.

Key benefits for stakeholders

The study presents an in-depth analysis of the global spirulina market along with the current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.

A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.

Identification of factors instrumental in changing the market scenario, rise in opportunities, and recognition of key players that can influence the market on a global and regional scale are provided in the report.

Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key Market Segments

By Type

  • Arthrospira Platensis
  • Arthrospira Maxima

By Application

  • Nutraceuticals
  • Food & Beverages
  • Cosmetics
  • Animal Feed
  • Others

By Formulation

  • Powder
  • Tablet & Capsule
  • Liquid
  • Granule & Gelling Agent

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Rest of LAMEA
  • List of key players profiled in the report
  • Cyanotech Corporation
  • DIC Corporation
  • Cabassi & Giuriati SpA
  • DDW
  • DOHLER GmbH
  • Dongtai City Spirulina Bio-engineering Co., Ltd.
  • Echlorial
  • E.I.D. Parry Limited
  • Givaudan international SA
  • Prolgae Spirulina Supplies Pvt. Ltd.
  • Dongtai City Spirulina Bio-engineering Co., Ltd.
  • Algenol Biofuels Inc.
  • Pond Technologies Inc
  • Sensient Technologies Corporation
  • List of the other key players (not included in the report) GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., Fraken Biochem Co., Ltd., and Far East Bio-Tec Co. Ltd.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings
    • 2.1.1.Top investment pockets
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Parent Market Overview
  • 3.3.Key Forces Shaping Spirulina Market
    • 3.3.1.Moderate bargaining power of suppliers
    • 3.3.2.High bargaining power of buyers
    • 3.3.3.High threat of new entrants
    • 3.3.4.Moderate threat of substitutes
    • 3.3.5.High intensity of rivalry
  • 3.4.Pricing Analysis
    • 3.4.1.Pricing Analysis, By Region, 2019 & 2027
  • 3.5.Market evolution/Industry roadmap
  • 3.6.Patent Analysis
    • 3.6.1.By Region (2012-2020)
    • 3.6.2.By Applicant
    • 3.6.3.By Year
  • 3.7.Market share analysis
  • 3.8.Value Chain Analysis
  • 3.9.Impact of government regulations on the global spirulina market
  • 3.10.Industry pain point analysis
  • 3.11.Case Studies
    • 3.11.1.Case Study
  • 3.12.Market trends
    • 3.12.1.U.S.
    • 3.12.2.China
  • 3.13.False perception on the use of spirulina
  • 3.14.How the companies have reacted to the negative information
  • 3.15.Marketing strategies for production segments
  • 3.16.Trends for consumption in distinct European market
  • 3.17.Use of spirulina for animal feeding
  • 3.18.Market dynamics
    • 3.18.1.Drivers
      • 3.18.1.1.Increase in demand for natural ingredient
      • 3.18.1.2.Promotion of the production of spirulina by government
      • 3.18.1.3.R&D of spirulina as commercial products
    • 3.18.2.Restraints
      • 3.18.2.1.Impact on spirulina production due to climate change
    • 3.18.3.Opportunities
      • 3.18.3.1.Untapped markets in the developing countries
      • 3.18.3.2.Easy to cultivate due to development in cultivation technology
  • 3.19.Impact Analysis of COVID-19 on Spirulina Market

CHAPTER 4:SPIRULINA MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast, by consumption side
    • 4.1.2.Market size and forecast, by production side
  • 4.2.Arthrospira Platensis
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast, by consumption side
    • 4.2.3.Market size and forecast, by production side
    • 4.2.4.Market analysis, by country
  • 4.3.Arthrospira maxima
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast, by consumption side
    • 4.3.3.Market size and forecast, by Production side
    • 4.3.4.Market analysis, by country

CHAPTER 5:SPIRULINA MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast, by consumption side
    • 5.1.2.Market size and forecast, by production side
  • 5.2.Nutraceuticals
    • 5.2.1.Key market trends and opportunities
    • 5.2.2.Market size and forecast, by consumption side
    • 5.2.3.Market size and forecast, by production side
    • 5.2.4.Market analysis, by country
  • 5.3.Cosmetics
    • 5.3.1.Key market trends and opportunities
    • 5.3.2.Market size and forecast, by consumption side
    • 5.3.3.Market size and forecast, by production side
    • 5.3.4.Market analysis, by country
  • 5.4.Food & beverages
    • 5.4.1.Key market trends and opportunities
    • 5.4.2.Market size and forecast, by consumption side
    • 5.4.3.Market size and forecast, by production side
    • 5.4.4.Market analysis, by country
  • 5.5.Animal Feed
    • 5.5.1.Key market trends and opportunities
    • 5.5.2.Market size and forecast, by consumption side
    • 5.5.3.Market size and forecast, by production side
    • 5.5.4.Market analysis, by country
  • 5.6.Other Applications
    • 5.6.1.Key market trends and opportunities
    • 5.6.2.Market size and forecast, by consumption side
    • 5.6.3.Market size and forecast, by production side
    • 5.6.4.Market analysis, by country

CHAPTER 6:SPIRULINA MARKET, BY FORMULATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast, by consumption side
    • 6.1.2.Market size and forecast, by production side
  • 6.2.Powder
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.Market size and forecast, by consumption side
    • 6.2.3.Market size and forecast, by production side
    • 6.2.4.Market analysis, by country
  • 6.3.Tablet & capsule
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Market size and forecast, by consumption side
    • 6.3.3.Market size and forecast, by production side
    • 6.3.4.Market analysis, by country
  • 6.4.Liquid
    • 6.4.1.Key market trends and opportunities
    • 6.4.2.Market size and forecast, by consumption side
    • 6.4.3.Market size and forecast, by production side
    • 6.4.4.Market analysis, by country
  • 6.5.Granule & gelling agent
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.Market size and forecast, by consumption side
    • 6.5.3.Market size and forecast, by production side
    • 6.5.4.Market analysis, by country

CHAPTER 7:SPIRULINA MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
    • 7.1.2.Market size and forecast, by production side
  • 7.2.North America
    • 7.2.1.Key market trends and opportunities
    • 7.2.2.North America market size and forecast, by type
    • 7.2.3.North America market size and forecast, by application
    • 7.2.4.North America market size and forecast, by formulation
    • 7.2.5.North America market size and forecast, by country
      • 7.2.5.1.U.S. market size and forecast, by type
      • 7.2.5.2.U.S. market size and forecast, by application
      • 7.2.5.3.U.S. market size and forecast, by formulation
      • 7.2.5.4.Canada market size and forecast, by type
      • 7.2.5.5.Canada market size and forecast, by application
      • 7.2.5.6.Canada market size and forecast, by formulation
      • 7.2.5.7.Mexico market size and forecast, by type
      • 7.2.5.8.Mexico market size and forecast, by application
      • 7.2.5.9.Mexico market size and forecast, by formulation
  • 7.3.Europe
    • 7.3.1.Key market trends and opportunities
    • 7.3.2.Europe market size and forecast, by type
    • 7.3.3.Europe market size and forecast, by application
    • 7.3.4.Europe market size and forecast, by formulation
    • 7.3.5.Europe market size and forecast, by country
      • 7.3.5.1.Germany market size and forecast, by type
      • 7.3.5.2.Germany market size and forecast, by application
      • 7.3.5.3.Germany market size and forecast, by formulation
      • 7.3.5.4.France market size and forecast, by type
      • 7.3.5.5.France market size and forecast, by application
      • 7.3.5.6.France market size and forecast, by formulation
      • 7.3.5.7.UK market size and forecast, by type
      • 7.3.5.8.UK market size and forecast, by application
      • 7.3.5.9.UK market size and forecast, by formulation
      • 7.3.5.10.Italy market size and forecast, by type
      • 7.3.5.11.Italy market size and forecast, by application
      • 7.3.5.12.Italy market size and forecast, by formulation
      • 7.3.5.13.Spain market size and forecast, by type
      • 7.3.5.14.Spain market size and forecast, by application
      • 7.3.5.15.Spain market size and forecast, by formulation
      • 7.3.5.16.Rest of Europe market size and forecast, by type
      • 7.3.5.17.Rest of Europe market size and forecast, by application
      • 7.3.5.18.Rest of Europe market size and forecast, by formulation
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends and opportunities
    • 7.4.2.Asia-Pacific market size and forecast, by type
    • 7.4.3.Asia-Pacific market size and forecast, by application
    • 7.4.4.Asia-Pacific market size and forecast, by formulation
    • 7.4.5.Asia-Pacific market size and forecast, by country
      • 7.4.5.1.Japan market size and forecast, by type
      • 7.4.5.2.Japan market size and forecast, by application
      • 7.4.5.3.Japan market size and forecast, by formulation
      • 7.4.5.4.China market size and forecast, by type
      • 7.4.5.5.China market size and forecast, by application
      • 7.4.5.6.China market size and forecast, by formulation
      • 7.4.5.7.India market size and forecast, by type
      • 7.4.5.8.India market size and forecast, by application
      • 7.4.5.9.India market size and forecast, by formulation
      • 7.4.5.10.Australia market size and forecast, by type
      • 7.4.5.11.Australia market size and forecast, by application
      • 7.4.5.12.Australia market size and forecast, by formulation
      • 7.4.5.13.Rest of Asia-Pacific market size and forecast, by type
      • 7.4.5.14.Rest of Asia-Pacific market size and forecast, by application
      • 7.4.5.15.Rest of Asia-Pacific market size and forecast, by formulation
  • 7.5.LAMEA
    • 7.5.1.Key market trends and opportunities
    • 7.5.2.LAMEA market size and forecast, by application
    • 7.5.3.LAMEA market size and forecast, by formulation
    • 7.5.4.LAMEA market size and forecast, by country
      • 7.5.4.1.Brazil market size and forecast, by type
      • 7.5.4.2.Brazil market size and forecast, by application
      • 7.5.4.3.Brazil market size and forecast, by formulation
      • 7.5.4.4.South Africa market size and forecast, by type
      • 7.5.4.5.South Africa market size and forecast, by application
      • 7.5.4.6.South Africa market size and forecast, by formulation
      • 7.5.4.7.Rest of LAMEA market size and forecast, by type
      • 7.5.4.8.Rest of LAMEA market size and forecast, by application
      • 7.5.4.9.Rest of LAMEA market size and forecast, by formulation

CHAPTER 8:COMPANY PROFILES

  • 8.1.ALGENOL BIOFUELS INC.
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
  • 8.2.CABASSI & GIURIATI SPA
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
  • 8.3.CYANOTECH CORPORATION
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.DDW INC.
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
  • 8.5.DIC CORPORATION
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
  • 8.6.DOHLER GmbH
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
  • 8.7.DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
  • 8.8.ECHLORIAL
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
  • 8.9.E.I.D. PARRY LIMITED
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
  • 8.10.GIVAUDAN INTERNATIONAL SA
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
  • 8.11.PROLGAE SPIRULINA SUPPLIES PVT. LTD.
    • 8.11.1.Company overview
    • 8.11.2.Company snapshot
    • 8.11.3.Operating business segments
    • 8.11.4.Product portfolio
  • 8.12.POND TECHNOLOGIES INC.
    • 8.12.1.Company overview
    • 8.12.2.Company snapshot
    • 8.12.3.Operating business segments
    • 8.12.4.Product portfolio
  • 8.13.SENSIENT TECHNOLOGIES CORPORATION
    • 8.13.1.Company overview
    • 8.13.2.Company snapshot
    • 8.13.3.Operating business segments
    • 8.13.4.Product portfolio
    • 8.13.5.Business performance